Atrovent Nasal Related Published Studies
Well-designed clinical trials related to Atrovent Nasal (Ipratropium Nasal)
Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. [2008.03]
The effect of ipratropium nasal spray on bronchial methacholine challenge. [2005.09]
Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. [2001.09]
Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study. [2001.05]
Ipratropium bromide increases the ability of the nose to warm and humidify air. [2000.09]
Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. [1999.08]
Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. [1999.04]
Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial. [1998.11]
Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection. [1998.03]
The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. [1998.01]
Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. [1997.06]
Ipratropium nasal spray in children with perennial rhinitis. [1997.05]
A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis. [1997.04]
Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea. [1996.12]
Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. [1996.07.15]
A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. [1995.05]
Product characteristics and pharmacokinetics of intranasal ipratropium bromide. [1995.05]
Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. [1994.11]
Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. [1994.03]
A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. [1992.12]
Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. [1992.12]
Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. [1992.08]
The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage. [1992.07]
Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis. [1992.07]
Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. [1992.06]
Vasomotor rhinitis and the systemic absorption of ipratropium bromide. [1990.06]
Treatment of non-allergic nasal hypersecretion with ipratropium and beclomethasone. [1990.06]
The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study. [1988.11]
Ipratropium bromide treatment of experimental rhinovirus infection. [1988.11]
Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide. [1988.06]
Well-designed clinical trials possibly related to Atrovent Nasal (Ipratropium Nasal)
Elevation of the nasal mucosal surface temperature after warming of the feet occurs via a neural reflex. [2003.06]
A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. [2003.04]
The anticholinergic treatment of allergic perennial rhinitis. [1992.12]
Combined antiviral and antimediator treatment of rhinovirus colds. [1992.10]
The parasympathetic system in exercise-induced rhinorrhoea. [1992.03]
Other research related to Atrovent Nasal (Ipratropium Nasal)
Intranasal ipratropium bromide for the common cold. [2013]
Intranasal ipratropium bromide for the common cold. [2011.07.06]
Intranasal ipratropium bromide for the common cold. [2011]
Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. [2010.05.01]
Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. [2010.04]
OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold. [2009.12]
Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold. [2009.04]
Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. [2007.01]
Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. [2005.01]
Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. [1995.05]
Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis. [1993]
Long-term safety and efficacy study of intranasal ipratropium bromide. [1990.02]
Intranasal ipratropium: literature abstracts and comments. [1989]
Ipratropium bromide in the treatment of the 'rhinorrhoea syndrome'. [1988.09]
Other possibly related research studies
Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance. [2003]
Cholinergic blockade does not alter the nasal congestive response to irritant provocation. [2002.09]
Posttraumatic pseudo-cerebrospinal fluid rhinorrhea. [2001.09]
Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. [2001.05]
Anticholinergic bronchodilators. [1999.12]
Optimizing treatment options. [1998.12]
Management of rhinitis--the specialist's opinion. [1998.12]
Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways. [1997.11]
Overview of comorbid associations of allergic rhinitis. [1997.02]
Cyclophosphamide-induced facial discomfort. [1994.02]
The use of intranasal anticholinergic agents in the treatment of nonallergic perennial rhinitis. [1992.12]
Intranasal anticholinergic therapy of rhinorrhea. [1992.12]
Brief report: therapeutic manipulations in severe nocturnal asthma. A nonconventional approach in a severe high-risk asthmatic. [1992]
Management of allergic rhinitis: focus on intranasal agents. [1989]
Nasal disorders and anticholinergic therapy. [1987]
Acute bacterial rhinosinusitis in adults: part II. Treatment. [2004.11.01]
Vasomotor rhinitis update. [2004.06]
Treating acute bronchiolitis associated with RSV. [2004.01.15]
Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. [2002]
Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? [2001]
Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis. [2000.07]
Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. [2000.01]
In vivo human models for the study of anticholinergic drugs. [1995.05]
Induction and relief of nasal congestion in ferrets infected with influenza virus. [1995.02]
Topical nasal sprays: treatment of allergic rhinitis. [1994.07]
Effects of antiallergic agents including levocabastine on experimental rhinitis in rats. [1994.03]
Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. [1993.05.05]
Topical pharmacotherapy for allergic rhinitis: new agents. [1992.02]
A gap in surface therapy: topical antihistamines. [1991.05]
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. [1991.04]
Optimum pharmacological management of chronic rhinitis. [1989.08]
Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood. [1989]
Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. [1988.03]
Treatment of the common cold. [2007.02.15]
Postnasal drip and chronic cough: An open interventional study. [2009.11]
Validation of guinea pig model of allergic rhinitis by oral and topical drugs. [2008.11]
|
